BlueStone Venture Partners
BlueStone Venture Partners is a Southwest‑rooted, life sciences venture capital firm that invests in early‑stage companies outside traditional US innovation hubs. The firm focuses on transformative platforms in Medical Devices, Diagnostics, Digital Health and Life Science Research Tools, providing growth capital, hands‑on strategic support, and access to industry partners and co‑investors.
BlueStone Venture Partners
Tucson, Arizona, United States, North America
Services
Growth Capital (Equity)
Provides growth capital to early‑stage life sciences companies; typical check sizes between $250,000 and $1,000,000. Willing to lead or co‑lead rounds.
Strategic and Operational Support
Hands‑on management and strategic planning support for portfolio companies, leveraging the team's operational and technical backgrounds.
Diligence & Research Support
Dedicated research and diligence execution to evaluate potential investments and support portfolio company milestones.
Network and Partner Access
Provides privileged access to strategic partners including investors, customers, advisors, and supply‑chain partners through existing deal pipelines and relationships.
Board Participation and Governance
Seeks a board seat as part of investments to provide governance and strategic oversight.
Growth Capital (Equity)
Provides growth capital to early‑stage life sciences companies; typical check sizes between $250,000 and $1,000,000. Willing to lead or co‑lead rounds.
Strategic and Operational Support
Hands‑on management and strategic planning support for portfolio companies, leveraging the team's operational and technical backgrounds.
Diligence & Research Support
Dedicated research and diligence execution to evaluate potential investments and support portfolio company milestones.
Network and Partner Access
Provides privileged access to strategic partners including investors, customers, advisors, and supply‑chain partners through existing deal pipelines and relationships.
Board Participation and Governance
Seeks a board seat as part of investments to provide governance and strategic oversight.
Portfolio
Referenced on BlueStone portfolio page; news item on securing financing to advance a cell separation platform.
#Life science tools (cell separation)
Referenced on BlueStone portfolio page; received U.S. 510(k) clearance for PlaqueIQ image analysis software.
#Cardiovascular imaging / medical software
Referenced on BlueStone portfolio page; multiple financing and regulatory milestones reported related to GammaTile therapy.
#Medical devices (GammaTile radiation therapy)
Referenced on BlueStone portfolio page; announced commercial availability of NTxscribe and plans for a biomanufacturing facility.
#Biomanufacturing / RNA enabling technologies
Referenced on BlueStone portfolio page; noted acquisition by Exact Sciences in site news.
#Diagnostics
Referenced on BlueStone portfolio page; received FDA Breakthrough Device designation for DCISionRT test.
#Diagnostics (breast cancer risk test)
Referenced on BlueStone portfolio page; news item on securing financing to advance a cell separation platform.
#Life science tools (cell separation)
Referenced on BlueStone portfolio page; received U.S. 510(k) clearance for PlaqueIQ image analysis software.
#Cardiovascular imaging / medical software
Referenced on BlueStone portfolio page; multiple financing and regulatory milestones reported related to GammaTile therapy.
#Medical devices (GammaTile radiation therapy)
Referenced on BlueStone portfolio page; announced commercial availability of NTxscribe and plans for a biomanufacturing facility.
#Biomanufacturing / RNA enabling technologies
Referenced on BlueStone portfolio page; noted acquisition by Exact Sciences in site news.
#Diagnostics
Referenced on BlueStone portfolio page; received FDA Breakthrough Device designation for DCISionRT test.
#Diagnostics (breast cancer risk test)